Keywords
type 2 diabetes mellitus
heart failure
diabetic cardiomyopathy
How to Cite
Abstract
Structural and/or functional heart abnormalities associated with T2DM were previously called "diabetic cardiomyopathy", but this term applied only to cases of HF in patients with T2DM without hypertension, coronary artery disease (CAD) and obesity. European experts in the new consensus document of the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases propose a new term - "diabetic myocardial disorder" (DMD). DMD is dеfіned as systolic or diastolic myocardial dysfunction in the presence of diabetes. Diabetes is rarely the only cause. Most often, heart damage develops if the patient has obesity, hypertension, chronic kidney disease (CKD) and CAD, which increase the risk of its occurrence. It was proposed a new scale for assessing the risk of HF in patients with T2DM — WATCH-DM. The main medicines for the prevention of HF in diabetes are sodium–glucose cotransporter 2 (SGLT2) inhibitors, Renin–angiotensin–aldosterone system (RAAS) blockers, beta-adrenergic blockers.
References
PM Seferovic, WJ Paulus, G Rosano, M Polovina, MC Petrie, PS Jhund, C Tschöpe, N Sattar, M Piepoli, Z Papp, E Standl, M A Mamas, P Valensi, A Linhart, N Lalic, A Ceriello, W Döhner, A Ristic, I Milinkovic, J Seferovic, F Cosentino, M Metra and AJS Coats. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases. European Journal of Heart Failure (2024). URL: https://doi.org/10.1002/ejhf.3347
Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: Acohort study in 1.9 million people. Lancet Diabetes Endocrinol 2015;3:105–113. URL: https://doi.org/10.1016/S2213-8587(14)70219-0
He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996–1002. URL: https://doi.org/10.1001/archinte.161.7.996
Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, et al.; PARADIGM-HF Investigators and Committees. Risk related to prediabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: Insights from Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial. Circ Heart Fail 2016;9:e002560. URL: https://doi.org/10.1161/ CIRCHEARTFAILURE.115.002560
Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: An observational study. Lancet 2011;378:140–146. URL: https://doi.org/10.1016/S0140-6736(11)60471-6
McAllister DA, Read SH, Kerssens J, Livingstone S, McGurnaghan S, Jhund P, et al.Incidence of hospitalization for heart failure and casefatality among 3.25 million people with and without diabetes mellitus. Circulation 2018;138:2774–2786. URL: https://doi.org/10.1161/ CIRCULATIONAHA.118.034986
Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30:595–602. URL: https://doi.org/10.1016/0002-9149(72)90595-4
Seferovic PM, Paulus WJ. Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes. Eur Heart J 2015;36:1718–1727. URL: https://doi.org/10.1093/eurheartj/ehv134
Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115:3213–3223. URL: https://doi.org/10.1161/CIRCULATIONAHA.106.679597